We need public health innovation from our governments, writes Abraar Karan As a clinician, I rarely see a patient die from covid-19 anymore. Those who end up in the hospital these days have benefited from the immense advances in clinical science that have brought us vaccines, monoclonal antibodies, and antivirals, and taught us how best to use these and other existing medications, such as steroids, to save our patients’ lives. Collectively, this is an enormous accomplishment. It’s not, however, the end of the pandemic. The end of covid-19 will not be a clinical feat, but a public health one. For months, doctors and health officials have been reminding people that they “have the tools”—specifically, the clinical tools—that mean most people won’t end up hospitalised or dead. But many people are still getting sick from infection, enough so to miss work; end up in the emergency department for evaluation; or end up with longer, lingering side effects, the consequences of which we cannot fully appreciate yet. Our current vaccines are not effective enough at stopping transmission1; and while future vaccines, such …

中文翻译：

---

covid-19 大流行将以公共卫生工具结束，而不是临床工具

我们需要政府的公共卫生创新，Abraar Karan 写道，作为一名临床医生，我很少再看到患者死于 covid-19。这些天最终住院的人受益于临床科学的巨大进步，这些进步为我们带来了疫苗、单克隆抗体和抗病毒药物，并教会了我们如何最好地使用这些药物和其他现有药物，如类固醇，来拯救我们的生命。患者的生活。总的来说，这是一项巨大的成就。然而，这并不是大流行的结束。covid-19 的终结将不是一项临床壮举，而是一项公共卫生壮举。几个月来，医生和卫生官员一直在提醒人们他们“拥有工具”——特别是临床工具——这意味着大多数人最终不会住院或死亡。但仍有许多人因感染而生病，足以错过工作；最终在急诊科进行评估；或者最终产生更长的、挥之不去的副作用，我们还不能完全理解其后果。我们目前的疫苗在阻止传播方面不够有效1；而未来的疫苗，比如……